The Insurance Helpline
Totally Insured Group // 0800 377 7763

A novel drug being tested in the US could bring hope to men diagnosed with the most aggressive form of prostate cancer.

The compound successfully shrank human prostate tumours in mice that were untreatable with current drugs, and showed some signs of arresting tumour growth in men with similar drug-resistant tumours.

Scientists found that the experimental drug caused the level of a prostate cancer marker to fall by at least 50 per cent in 13 of 30 patients with advanced disease that had resisted other treatments.

It is hoped that in future the compound, which tackles prostate cancer in a different way to other drugs, could offer new hope to patients.

Dr Philip Kantoff, from the Dana-Farber Cancer Institute in Boston, told ScienceNOW daily news: "It’s possibly a new and better way of treating prostate cancer."

This development could be important for people wishing to obtain prostate cancer/” target=”_self”>cancer life insurance.

Prostate cancer rates have tripled over the last 30 years in the UK, but this thought to be largely due to better detection methods.



The Insurance Helpline specialises in obtaining cover for people living with cancer.

This entry was posted on Wednesday, April 8th, 2009 at 4:01 pm and is filed under Medical Developments and treatments.